Eckelman Brendan P.

Eckelman Brendan P. is listed in filings as Chief Scientific Officer at Inhibrx Biosciences, Inc.. This profile follows SEC Form 4 activity through May 30, 2024, including sale activity. Recent filings connect the profile to Inhibrx Biosciences, Inc. (INBX). The current snapshot covers public activity from Mar 12, 2024 to May 30, 2024. Reported amounts are shown as $4.8M to $224.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.